Click to Share
 
 
  1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account

insulin News

  + XML/RSS  



By Mary Ann Liebert, Inc., publishers
An automated on/off feature built into insulin pump systems can suspend insulin delivery when it detects low blood glucose levels, significantly reducing the severity and duration of hypoglycemia in individuals with type 1 diabetes.

By Healthwise Exercise
HealthWise Exercise, the producer of Suzanne Andrews’ Functional Fitness DVDs, recently announced the release of their newest doctor recommended fitness DVD, Functional Fitness with Suzanne Andrews: Stop Diabetes Now.

By Terry Nobly
MyidealCARE™ has been working with local physicians and senior citizen centers in the Thomasville, Georgia area to bring valuable detailed information about diabetes, diabetic supplies, and blood glucose monitoring systems to seniors direct.

By Terry Nobly
MyidealCARE™ is showcasing the Fora® V10 compact, newer talking diabetic meters which are less painful to use as they allow alternate site testing (AST) at areas around the body, instead of only using the fingertips for diabetic sampling.

By McCoy Press
Recent research reported in the Journal of Pediatric, Maternal & Family Health - Chiropractic reveals that chiropractic may play an important role in helping children suffering from Type I Diabetes.

By Harris County Hospital District
People with diabetes face a figurative mine field of savory holiday dishes and desserts from pumpkin pies topped with whipped cream to cranberries and cornbread dressing. So what can a diabetes sufferer do to stay healthy? Find out here.

By Netscribes
Netscribes (India) Pvt. Ltd., launches its Syringes & Needles Market in India Report 2011 covering one of the emerging markets in India with strong growth prospects . It is a part of Netscribes’ Healthcare Series reports.

By Joe Walsh
Piribo, the online destination for Pharma intelligence, has added a new report.

By O2 Media, Inc.
“Appearing on “The Balancing Act” is a great opportunity to talk about how the DRI was created for one reason – to cure diabetes – which is and will continue to be its singular focus until that goal is reaches."

By IMARC Group
A new report from IMARC Group finds that one of the biggest advantages of biopharmaceuticals over conventional small molecule drugs is their high efficacy and target oriented nature.

By Krishna Sharma
Driven by an increasing prevalence of diabetes, the total market for Insulin and Non-Insulin Antidiabetics is expected to reach sales worth US$ 2803 Million by 2015.

By Janet Vasquez/Alex Aversa
TurboCharged® is a groundbreaking 8-Step program that defies common weight-loss theories.

By Global Research & Data Services
Global Research & Data Services is going to publish several market analyses about the markets for insulin around the world.

By Dr.Victor Marchione
Vitamin D, what have you not done for us lately? The sunshine vitamin, constantly in health news, continually being at the heart of health breakthroughs, and the king of natural supplements, plays six intricate roles in our bodies.

By Fast Market Research
New Pharmaceuticals research report from Datamonitor is now available from Fast Market Research

By Darrel Simpson
Whether you read a health magazine or consult a health professional they have only one thing to tell you eat colored vegetables and try to stay away from white carbohydrate food as far as possible.

By Dr. Victor Machione
A cold-like virus may be responsible for triggering the onset of type 1 diabetes.

By reports-research.com
The FDA has requested further Phase III trials of MannKind's inhaled insulin Afrezza with its next generation Dreamboat inhaler before it can be approved.

By David Wong
Pretium Ventures Analyst believes that Chinese Insulin market will grow significantly over the next 5-10 years and that United Laboratories could take a substantial portion of that market.

By Angela Minelli
More Than 105 Million Americans Now Have Diabetes or Prediabetes

By Researchinchina
ResearchInChina, the vertical portal for Chinese business intelligence, announces the release of a new report - China Insulin Industry Report, 2010.

By Kalorama Information
Indian scientists discovered a novel form of insulin that can keep blood glucose levels down for up to three months.

By Kalorama Information
Drug manufacturers have tried for years to develop oral insulin and have not had any success. But scientists are developing special coatings for insulin pills that prevent stomach acid from destroying them.

By Kavin Teega
After completing the clinical trial on over 30 patients with effectiveness at 100%, Sino Stem Cells, introduces diabetes clinically. 62.9% reduced insulin dosage by 50%. 3.7% of Type 1 and 11.1% of Type 2 could completely stop insulin injections.

By Rajesh Gunnam
The Global Diabetes Market is Lucrative Despite the Major Drugs in the Market being Associated with Heart Risks

By Kalorama Information
Novel pharmacological and biological approaches to disease are calling for novel systems of delivering therapies.

By Celeste Bailey, Ph.D., AMCR Institute
AMCR Institute is recruiting volunteers with type 2 diabetes and a history of heart problems to participate in a long-term clinical trial

By Fast Market Research
New Medical Devices research report from GlobalData is now available from Fast Market Research

By Bharatbook
Bharatbook added a new report on "The Top 10 Biotechnology Companies: Positioning, performance and SWOT analyses" which gives Overview of the global biotech industry.

By Bharatbook
Bharatbook added a new report on "The World Market for Diabetes Treatments" which discusses treatment for diabetes complications and natural and herbal treatments.

By Fast Market Research
Fast Market Research recommends "Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline" from Datamonitor, now available

By Neuropathy Treatment Group
Diabetics can now find help in curbing those high carb cravings through the use of chromium in the form of a spray.

By Diane Kress, RD CDE
Excess production of the hormone insulin can increase the chance of developing breast cancer. Is this little publicized fact the missing link to stopping breast cancer in its tracks? Pass the information forward as excess insulin is controllable.

By J.Roberts
Develop key strategic initiatives by understanding the key focus areas of leading companies.

By J.Roberts
Develop business strategies by understanding the trends and developments that are driving the insulin pumps market globally.

By reports-research.com
GlobalData’s medical equipment report, Insulin Pumps - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 provides key data, information and analysis on the global insulin pumps market.

By Byron J. Richards, CCN
The thiazolidinedione diabetes drugs Avandia and Actos will break your bones and cause heart failure. DHA will help preserve your bones and rejuvenate your heart’s function. They all activate PPAR gamma.

By Byron J. Richards, CCN
Potassium is highly concentrated in your cells, whereas sodium (salt) is concentrated between your cells. New science is showing that a lack of potassium is a primary reason why salt can cause high blood pressure and cardiovascular damage.

By MedMarket Diligence, LLC
As well established as the practices are for the management of types 1 and 2 diabetes, a raft of new technologies, from modest to radical, are steadily entering clinical practice and the industry, according to a new report from MedMarket Diligence.

By Fast Market Research
Fast Market Research recommends "Diabetes Care Devices: Emerging Countries (China, India, Brazil) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016" from GlobalData, now available

By Fast Market Research
Recently published research from GlobalData, "Animas Corporation Market Share Analysis", is now available at Fast Market Research

By reports-research.com
GlobalData’s new report - Diabetes Care Devices: Emerging Countries (China, India, Brazil) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016 - provides key data, information and analysis on the diabetes care devices market.

By GlobalData
The Global Insulin Pumps Market is Forecast to Reach $1,051m in 2016 after Growing at a CAGR of 9% During 2009-2016

By MedMarket Diligence, LLC
The growing global prevalence of type 1 and 2 diabetes, driven by obesity and other forces, is creating strong clinical demand for a diverse set of diagnosis, monitoring and treatment products that are steadily evolving to better manage the disease.

By Renub Research
Summary - Renub Research has announced the addition of the “Global Diabetes Market Trends & Future Forecast – Diabetes Drug (Anti-Diabetic Drug), Insulin, DPP-IV, GLP-1" report to their offering

By Fast Market Research
Fast Market Research recommends "Diabetes Care Devices Market In Brazil, Russia, India & China (BRIC)" from Markets and Markets, now available

By Bharatbook
Bharatbook added a new report on "Global Diabetes Market Trends & Future Forecast - Diabetes Drug (Anti-Diabetic Drug), Insulin, DPP-IV, GLP-1" into its market report catalogue for reselling.

By Fast Market Research
New Medical Devices market report from GlobalData: "United Kingdom Diabetes Care Devices Market Outlook to 2016"

By Fast Market Research
Recently published research from GlobalData, "Argentina Diabetes Care Devices Market Outlook to 2016", is now available at Fast Market Research

By Fast Market Research
New Medical Devices research report from GlobalData is now available from Fast Market Research



Page:



  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Service
  5. Copyright Notice
  6. About
  7. Advertise
Like PRLog?
2.8K1.1K1.1K
Click to Share